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Antispasmodic propertyMicrobial transformation stands out among the many possible semi-synthetic strategies employed to
increase the variety of chemical structures that can be applied in the search for novel bioactive com-
pounds. In this paper we obtained ent-pimaradienoic acid (1, PA, ent-pimara-8(14),15-dien-19-oic acid)
derivatives by fungal biotransformation using Aspergillus niger strains. To assess the ability of such com-
pounds to inhibit vascular smooth muscle contraction, we also investigated their spasmolytic effect,
along with another ﬁve PA derivatives previously obtained in our laboratory, on aortic rings isolated from
male Wistar rats. The microbial transformation experiments were conducted at 30 C using submerged
shaken liquid culture (120 rpm) for 10 days. One known compound, 7a-hydroxy ent-pimara-8(14),15-
dien-19-oic acid (2), and three new derivatives, 1b-hydroxy ent-pimara-6,8(14),15-trien-19-oic acid
(3), 1a,6b,14b-trihydroxy ent-pimara-7,15-dien-19-oic acid (4), and 1a,6b,7a,11a-tetrahydroxy ent-
pimara-8(14),15-dien-19-oic acid (5), were isolated and identiﬁed on the basis of spectroscopic analyses
and computational studies. The compounds obtained through biotransformation (2–5) did not display a
signiﬁcant antispasmodic activity (values ranging from 0% to 16.8% of inhibition); however the previously
obtained diterpene, methyl 7a-hydroxy ent-pimara-8(14),15-dien-19-oate (8), showed to be very effec-
tive (82.5% of inhibition). In addition, our biological results highlight the importance to study the anti-
spasmodic potential of a large number of novel diterpenes, to conduct further structure–activity
relationship investigations.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
The plant kingdom is a rich and promising source of novel bio-
logically active chemical entities.1,2 Not only can natural com-
pounds serve as new drugs themselves, but they can also be
suitable prototypes to optimize drug structure via a number of
semi-synthetic strategies1,3, generating compounds with biological
properties distinct from those of the parent structure.
Microbial transformation stands out among the many possible
semi-synthetic strategies employed in drug discovery: it increases
the variety of chemical structures that can be applied in the search
for novel bioactive compounds4,5, leading to new sustainable
routes to synthesize ﬁne chemical and drugs.6,7 Microbial
enzymatic systems can perform highly regio- and stereoselectivereactions at non-activated carbons, which is difﬁcult to achieve
by classic organic chemistry.4,6,8,9 Strains of Aspergillus, for exam-
ple, can introduce hydroxyl groups into different classes of bioac-
tive natural compounds, such as terpenoids4,10, ﬂavonoids11,
coumarins12, and lignans.13
Diterpenes are a class of plant-derived compounds with a wide
spectrum of biological actions—they possess antinoceptive and
anti-inﬂamatory14, antiparasitic15, antimicrobial16,17, and antitu-
mor18 activities. In particular, ent-pimaradienoic acid (PA, ent-pimar-
a-8(14),15-dien-19-oic acid), a diterpene with a well-established
antibacterial effect19, has also attracted considerable attention from
the scientiﬁc community because it inhibits phenylephrine-, KCl-,
and CaCl2-induced vascular contraction. Therefore, PA might be
potentially applicable in the treatment of arterial hypertension.20
Considering the semi-synthetic potential of fungal biotransfor-
mation and as part of our ongoing efforts to explore the antihyper-
tensive potential of diterpenes5,7,10,20, in this paper we obtained PA
derivatives by fungal biotransformation using Aspergillus niger
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smooth muscle contraction, we also investigated their spasmolytic
effect, along with another ﬁve PA derivatives previously obtained
in our laboratory, on aortic rings isolated from male Wistar rats.
2. Materials and methods
2.1. General procedures
The NMR spectra were run on a Bruker DPX 400 spectrometer
(400 MHz for 1H and 100 MHz for 13C). Samples were dissolved
in CDCl3, and the spectra were calibrated with the solvent signals
at d 7.26 (1H) and d 77.0 (13C). The biotransformation procedures
were performed on a Cientec CT-713 rotary shaker. The high-
resolution ESI-MS spectra were recorded on an Ultro-TOF Bruker
apparatus ﬁtted with an electrospray ion source operating in the
positive ion mode. Optical rotation of novel compounds were
measured in CHCl3 in a JASCO DIP-370 polarimeter.
2.2. Substrate and microorganisms
ent-Pimara-8(14),15-dien-19-oic acid (PA, 1, 600.0 mg) was iso-
lated from the dichloromethane extract of Viguiera arenaria roots,
as previously described by Ambrósio et al.21 The A. niger strain used
in the biotransformation processes was provided by Prof. Dr. Suraia
Said from the Faculty of Pharmaceutical Sciences of Ribeirão Preto,
University of São Paulo, Brazil. This microorganism was main-
tained as a conidial suspension on silica gel (6-12 mesh, grade
40, desiccant-activated), at 4 C.
2.3. Microbial transformation
The microbial transformation experiments were conducted
using submerged shaken liquid culture and two-stage fermenta-
tion procedures. An inoculum of 2.1  106 conidia mL1 was asep-
tically added to seven Erlenmeyer ﬂasks (1000 mL) containing
500 mL of seed medium, as previously described in the literature.22
Cultures were incubated at 30 C using a shaker operating at
120 rpm. After 48 h of incubation, the resulting mycelia were har-
vested, rinsed, and aseptically transferred to seven Erlenmeyer
ﬂasks (2000 mL) containing 1000 mL of sterile medium consisting
of sucrose (3.0%), NaNO3 (0.2%), K2HPO4 (0.05%), MgSO47H2O
(0.05%), KCl (0.05%), and FeSO4. 7H2O (0.001%). After 24 h, 25 mL
of 20.0 mg mL1 PA in dimethylsulfoxide (DMSO) was equally dis-
tributed among the seven ﬂasks, which were incubated again.
Incubation was stopped after ten days, and the cultures were ﬁl-
tered. The resulting aqueous layer was extracted with ethyl acetate
(14  1000 mL; EtOAc), to yield the extract labeled AnE (A. niger
extract; 1.70 g) after solvent evaporation. Culture (culture medium
containing microorganisms incubated with DMSO only) and sub-
strate (sterile medium containing the same amount of PA incu-
bated under the experimental condition) controls were also
prepared for this strain.
2.4. Isolation of diterpenes
AnE was ﬁrst chromatographed over silica gel 60H (Merck, art.
7736) using vacuum liquid chromatography; an increasing gradi-
ent of EtOAc in n-hexane was used as eluent, which afforded seven
fractions of 300 mL each: AnE1 (13.4 mg; n-hexane), AnE2
(30.2 mg; 20% EtOAc), AnE3 (201.0 mg; 40% EtOAc), AnE4
(112.5 mg; 60% EtOAc), AnE5 (189.3 mg; 80% EtOAc), AnE6
(125.0 mg; EtOAc), and AnE7 (975.5 mg; MeOH). Fraction AnE3
was initially partitioned by medium pressure chromatography
(ﬂash chromatography) using an isocratic n-hexane/EtOAc 4:1
mixture as the mobile phase; ﬁve new fractions were obtained(AnE3.1-AnE3.5). 7a-Hydroxy ent-pimara-8(14),15-dien-19-oic
acid (2; 42.0 mg) was isolated from fraction AnE3.2 (85.0 mg) after
classic chromatography (n-hexane/EtOAc 7:3 + 1% HOAc). TLC
analysis (Whatman, 250.0 lm layer) of AnE4 revealed a main spot
that was puriﬁed by ﬂash chromatography (n-hexane/CHCl3
1:1 + 1% HOAc), to furnish diterpene 3 (87.3 mg; 1b-hydroxy ent-
pimara-6,8(14),15-trien-19-oic acid). AnE5 was chromatographed
by classic chromatography (n-hexane/EtOAc 1:4), which yielded
60 fractions of 10 mL each; these fractions were grouped into six
fractions (AnE5.1–AnE5.6) after TLC analysis, and fraction AnE5.4
corresponded to the diterpene 1a,6b,14b-trihydroxy ent-pimara-
7,15-dien-19-oic acid (4; 40.0 mg). Finally, compound 5
(33.8 mg; 1a,6b,7 a,11a-tetrahydroxy ent-pimara-8(14),15-dien-
19-oic acid) was isolated from fraction AnE6 by ﬂash chromatogra-
phy using n-hexane/EtOAc 2:3 + 1% HOAc as eluent. The 1H NMR
spectra of fraction AnE7 did not display characteristic signals of
ent-pimarane-type diterpenes.
2.5. Preparation of endothelium-intact vessels
Male Wistar rats weighing between 200 and 250 g (50–60 days
old) were anesthetized and killed by aortic exsanguinations in
accordance with the Ethical Animal Committee from the University
of Franca. The thoracic aorta was quickly removed, cleaned of
adherent connective tissues, and cut into rings (each one measur-
ing 4–5 mm long). Two stainless-steel stirrups were passed
through the lumen of each ring. One stirrup was connected to an
isometric force transducer, to measure tension in the vessels. The
rings were placed in a 5-mL organ chamber containing Krebs solu-
tion, gassed with 95% O2/5% CO2, and maintained at 37 C. The
Krebs solution consisted of (mmol L1): NaCl, 118.0; KCl, 4.7; KH2-
PO4, 1.2; MgSO4, 1.2; NaHCO3, 15.0; Glucose, 5.5; and CaCl2, 2.5.
After pH checking (pH 7.0), the rings were stretched until they
reached a basal tension of 1.0 g, determined by length-tension
relationship experiments, and were allowed to equilibrate for
60min; during this time, the bath ﬂuid was changed every
15–20min. Endothelial integrity was assessed qualitatively by the
degree of relaxation caused by acetylcholine (1 lmol L1) in the
presence of contractile tone induced by phenylephrine
(0.1 lmol L1). To study endothelium-intact vessels, a ring was dis-
carded if relaxation with acetylcholine was not 80% or greater.
2.6. Effect of PA derivatives on phenylephrine-induced rat aorta
contractions
After equilibration, cumulative concentration–response curves
for phenylephrine (1010–105 M) were constructed. The curves
were obtained using endothelium-intact rings and applying a step-
wise increase in phenylephrine concentration. Additions were
made as soon as a steady response was reached at the preceding
concentration. The curves were determined without pre-incuba-
tion (control group) or after 60-min incubation with PA derivatives
at a concentration of 100 lM, as previously described by our re-
search group for PA.23 The maximum effect elicited by the tested
compound (Emax) in the absence (control group) or presence of
PA derivatives was used as the pharmacological parameter to cal-
culate the percentage of inhibition for each compound. The diter-
penes which promoted a percentage of inhibition that was not
statistically different from its Emax as compared with the control
group were considered to promote 0% inhibition.
2.7. Statistical analysis
Statistical differences between the Emax values were calculated
using one-way analysis of variance (ANOVA). Post-hoc comparisons
were performed after ANOVA analysis, using a Newman–Keuls
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values of less than 0.05 were considered signiﬁcant in all the analy-
ses. Data represent themeanof responses observed in vascular rings
of six to seven animals.
2.8. Computational methods
We used the program package GAUSSIAN09, the B3LYP hybrid
functional, and Dunning’s cc-pVDZ basis set to optimize the full
geometry and calculate the vibrational frequency. The nature of
the stationary point was determined using the eigenvalues ob-
tained from the harmonic vibration analysis. 1H and 13C NMR
chemical shift values were calculated within the Gauge-Indepen-
dent Atomic Orbital (GIAO) using the ‘mixed’ option, which re-
quires stepwise calculation of spin–spin coupling constants and
includes the Fermi Contact contribution, improving the ﬁnal
results.24 All the calculations were performed at the B3LYP/cc-
pVDZ level of theory. In order to compare the GIAO isotropic mag-
netic shielding (IMS) values with experimental chemical shifts, the
NMR parameters of the reference molecule tetramethylsilane
(TMS) were calculated at the same level of theory. The hydroxyl
groups were oriented in the a and b positions and at different car-
bon atoms, to check the structure and stereochemistry assigned to
compounds 3–5. The computational data obtained in this work
qualitatively agree with those previously published for NMR calcu-
lations involving diterpenoids.25,26
3. Results and discussion
3.1. Microbial transformation of PA and computational studies
Ten-day incubation of ent-pimaradienoic acid (1, PA) with
Aspergillus niger afforded four derivatives (2–5); Figure 1 illustrates
the chemical structures of PA, the metabolites obtained through
catalysis using A. niger (2–5), as well as the other derivatives (6–
10) previously obtained by our research group5,10 that were also
tested on aortic rings isolated from male Wistar rats.
Our NMR spectroscopic results allowed us to identify com-
pound 2 as 7a-hydroxy ent-pimara-8(14),15-dien-19-oic acid.27
In this paper, we describe the diterpenes 3–5 for the ﬁrst time,
on the basis of NMR spectroscopic analyses (1H and 13C NMR,COOH
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Figure 1. Chemical structures of the1H–1H COSY, HMBC, HMQC, and NOE); computational methods
also supported the spectrometric identiﬁcation of the novel diter-
penes. Tables 1 and 2 list the 1H and 13C NMR chemical shifts; Fig-
ures 2 and 3 represent the main HMBC and NOE correlations,
respectively.
Several authors have investigated the microbial transformation
of natural compounds by Aspergillus strains; these species promote
the introduction of hydroxyl groups into various plant-derived
products.4,10 Here, we found that A. niger catalyzed the hydroxyl-
ation of non-activated carbons in the chemical structure of PA,
mainly at C-1, C-6, C-7, C-11, and C-14 (Fig. 1), which is difﬁcult
to achieve by classic synthetic methodologies and represents an
important strategy to introduce a reactive center into the poorly
functionalized PA skeleton. Besides this reaction, A. niger also pro-
moted dehydrogenation at C-6 and C-7 in compound 3, as well as
transmigration of the double bond from C-8/C-14 to C-7/C-8 in
compound 4. The whole process yielded about 8, 16.7, 6.9, and
5.6% of compounds 2, 3, 4, and 5, respectively, on the basis of their
weights relative to the starting substrate.
We obtained compound 3 (colorless and amorphous solid, ½a25D
410, c 0.0013, CHCl3); we determined its molecular formula as
C20H28O3 using HR-ESIMS, which evidenced an increment of
14 a.m.u. relative to PA. The 1H NMR spectrum of compound 3 (Ta-
ble 1) presented the characteristic PA signals corresponding to the
vinylic protons H-14 (dH 5.29, 1H, s(br)), H-15 (dH 5.71, 1H, dd,
J = 17.2, 10.2 Hz), H-16a (dH 4.84, 1H, dd, J = 17.2, 1.7 Hz), and H-
16b (dH 4.96, 1H, dd, J = 10.2, 1.7 Hz); we also detected the typical
methyl protons H-17 (dH 1.05), H-18 (dH 1.31), and H-20 (dH 0.68).
The signal relative to one oxymethine proton appeared at dH 3.57
(1H, dd, J = 11.4, 4.9 Hz). The HMBC spectrum revealed long-range
correlations, particularly between H-20 (dH 0.68) and the carbinolic
carbon at dc 78.2, suggesting the presence of a hydroxyl group at C-
1. We assigned the a-orientation to OH-1, on the basis of data pre-
viously reported for correlated compounds containing a hydroxyl
group at C-1 and considering the coupling constants of the germi-
nal proton in the 1H NMR spectrum.4,28,29 Computational methods
corroborated this assignment: the coupling constant calculated for
H-1 (J = 11.6, 5.5 Hz) was quite similar to the experimental value
(J = 11.5, 4.9 Hz). Compared with PA, the 1H NMR spectrum of com-
pound 3 also indicated the presence of two oleﬁnic protons at dH
6.04 (1H, dd, J = 10.2, 1.7 Hz) and dH 5.97 (1H, d, J = 10.2 Hz). InCOOH
H
OH
OH
OH
4
O
R1
H R2
8. R1=COOCH3; R2=OH
9. R1= CH2OH; R2=H
10. R1= COOCH3; R2=H
pimarane-type diterpenes 1-5.
Table 1
1H NMR chemical shifts of metabolites 3–5 (CDCl3, d values in ppm)a
1H 3 3b 4 4b 5 5b
1 3.57
dd (4.9, 11.4)
3.13
(5.5, 11.6)
3.70
dd (4.6, 5.1)
3.41
(3.1, 4.2)
3.82
t (6.3)
3.29
(3.8, 3.7)
5 1.64
d (5.1)
1.70
(3.7)
1.86
d (5.0)
2.36
6 6.04dd (1.7, 10.2) 6.15
(2.9, 11.3)
4.90
ddd (5.1, 7.2, 2.2)
4.54
(3.7, 7.5, 1.9)
4.67
dd (1.2, 5.0)
4.36
(2.4, 3.9)
7 5.97
d (10.2)
5.88
(11.3)
6.02
dd (5.1, 2.4)
6.30
(7.5, 3.3)
4.57
d (1.2)
4.01
(3.9)
9 2.1
d (7.9)
2.83
(7.9)
11 3.92
ddd (3.8, 7.9, 11.9)
3.87
(5.8, 7.9, 11.7)
14 5.29
s
5.18 4.00
s
3.48 5.77
s
5.54
15 5.71
dd (10.2, 17.2)
5.74
(11.2, 17.6)
5.66
dd (10.4, 17.2)
5.45
(13.0, 19.0)
5.70
dd (10.5, 17.4)
5.67
(11.2, 17.6)
16a 4.84
dd (1.7, 17.2)
4.95
(2.3, 17.6)
4.97
dd (1.7, 17.2)
5.20
(1.3, 19.0)
4.80
dd (1.2, 17.4)
5.04
(1.9, 17.6)
16b 4.96
dd (1.7, 10.2)
5.06
(2.3, 11.2)
5.07
dd (1.7, 10.4)
5.52
(1.3, 13.0)
4.99
dd (1.2, 10.5)
5.21
(1.9, 11.2)
17 1.05
s
1.04 1.08
s
1.07 1.10
s
0.99
18 1.31
s
1.12 1.29
s
1.23 1.28
s
1.24
20 0.68
s
0.60 0.89
s
0.98 0.81
s
0.81
a Assignments based on HMBC and 1H–1H COSY.
b 1H NMR chemical shifts and coupling constants obtained from computational methods.
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Figure 2. Main HMB
Table 2
13C NMR chemical shifts of compounds 3–5 (CDCl3, d values in ppm)a
13C 3 3b 4 4b 5 5b
1 78.2 80.4 74.2 75.4 71.5 76.0
2 29.9 33.9 26.5 29.5 28.5 29.4
3 35.1 38.7 30.2 37.0 27.3 37.5
4 42.6 47.1 42.5 47.2 42.5 48.3
5 54.2 60.7 50.9 55.7 50.6 52.6
6 128.8 127.9 73.3 66.0 79.7 72.9
7 126.2 129.1 120.9 122.4 70.3 80.7
8 135.9 139.3 147.9 145.3 137.8 146.8
9 49.6 55.2 44.8 47.6 53.3 49.1
10 43.6 49.1 38.2 46.8 40.5 52.6
11 21.6 25.2 21.9 23.3 64.4 69.2
12 35.3 39.5 30.8 40.2 44.4 50.2
13 38.4 44.9 40.5 49.1 39.4 45.3
14 132.6 132.8 78.2 79.2 136.9 131.4
15 146.9 148.6 142.8 144.1 144.8 145.7
16 113.1 113.0 114.3 115.3 113.7 114.5
17 28.8 32.2 24.4 32.4 29.4 32.8
18 28.5 31.4 23.5 30.0 23.8 30.5
19 181.2 172.2 181.8 176.2 181.0 175.0
20 6.8 8.1 10.4 17.7 12.0 18.3
a Assignments based on HMQC and HMBC.
b 13C NMR chemical shifts obtained from computational methods.
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Figure 3. Main NOE correlations.
M. E. Severiano et al. / Bioorg. Med. Chem. 21 (2013) 5870–5875 5873the HMBC spectra (Fig. 2), the proton resonance at dH 5.97 corre-
lated with C-8 (dc 135.9), while the chemical shift of the hydrogen
at dH 6.04 correlated with C-5 (dc 54.2), attesting to the presence of
a double bond between C-6 and C-7. Therefore, we established the
structure of metabolite 3 as 1b-hydroxy ent-pimara-6,8(14),15-tri-
en-19-oic acid.
Using HR-ESIMS, we determined a molecular formula of
C20H30O5 for compound 4 (½a25D 243, c 0.0014, CHCl3); this repre-
sents an increment of 48 a.m.u. compared with PA and suggests
that compound 4 contains three hydroxyl functionalities. The 1HOH
COOH
H
OH
OH
HO
OH
4 5
C correlations.
Table 3
Effect of PA derivatives on rat aorta contractions induced by phenylephrine
Compounds % of inhibition Compounds % of inhibition
PA (1)a 73.2 6 50.8
2 16.8 7 61.5
3 12.5 8 82.5
4 0.0 9 58.8
5 0.0 10 10.5
a % of inhibition displayed by PA previously reported (Tirapelli et al. 23).
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tic signals of PA resonance at dH 5.66 (1H, dd, J = 17.2, 10.4 Hz),
4.97 (1H, dd, J = 17.2, 1.7 Hz), 5.07 (1H, dd, J = 10.4, 1.7 Hz), 1.08
(3H, s), 1.29 (3H, s), and 0.89 (3H, s), attributed to H-15, H-16a,
H-16b, H-17, H-18, and H-20, respectively. The 1H (Table 1) and
13C NMR (Table 2) data of compound 4 also revealed three oxyme-
thine protons, at dH 3.70 (1H, dd, J = 4.6, 5.1 Hz), 4.00 (1H, s), and
4.90 (1H, ddd, J = 5.1, 7.2, 2.2 Hz); such protons do not exist in
the chemical structure of PA. The HMBC spectrum of compound
4 (Fig. 2) evidenced that the proton resonance at dH 3.70 correlated
with C-2 (dc 26.5), C-9 (dc 44.8), C-10 (dc 38.2), and C-20 (dc 10.4),
indicating a hydroxyl group at C-1 (dc 74.2). On the basis of the
small coupling constants values veriﬁed for H-1, we assigned b-ori-
entation (equatorial-axial and equatorial-equatorial coupling con-
stants) to OH-1. Computational methods conﬁrmed this
attribution: the calculated coupling constants (J = 3.1, 4.2 Hz) were
similar to the experimental values (dd, J = 4.6, 5.1 Hz; Table 1). The
1H NMR spectrum of compound 4 did not contain the typical sin-
glet attributed to H-14 in the chemical structure of PA, indicating
that A. niger altered the endocyclic double bond between C-8 and
C-14. This spectrum also denoted the presence of a vinylic proton
at dH 6.02 (1H, dd, J = 5.1, 2.4 Hz), which correlated with C-5 (dc
50.9), C-9 (dc 44.8), and C-14 (dc 78.2) in the HMBC spectrum
(Fig. 2). The 1H NMR spectrum also evidenced the long-range cor-
relations between the resonance of two other oxymethine protons:
dH 4.00 (1H, s, H-14) correlated with C-7 (dc 120.9), C-8 (dc 147.9),
C-12 (dc 30.8), C-13 (dc 40.5), and C-15 (dc 142.8); dH 4.90 (1H, ddd,
H-6, J = 7.2, 5.1, 2.2 Hz) correlated with C-7 (dc 120.9) and C-8 (dc
147.9). All these data pointed to the transmigration of the typical
PA endocyclic double bond from C-8/C-14 to carbons C-7 (dc
120.9)/C-8 (dc 147.9) and indicated the presence of OH functional-
ities at C-6 (dc 73.3) and C-14 (dc 78.2). The 1H–1H COSY experi-
ment showed that H-6 correlated with H-5 (dH 1.64) and H-7 (dH
6.02); it also revealed a long-range coupling between H-6 and H-
9 (m, dH 2.23), justifying the multiplicity of the signal attributed
to H-6 (ddd, J = 7.2, 5.1, 2.2 Hz). We observed the same long-range
coupling between H-7 and H-9. The hydroxyl group at C-6 was a-
oriented, as attested by the NOE enhancements (Fig. 3) of H-6 with
H-5 (dH 1.64), H-7 (dH 6.02), and H-18 (dH 1.29). In turn, we found
NOE effects involving H-14 with H-7 and H-17, which conﬁrmed
that OH-14 was also a-oriented. Therefore, we identiﬁed com-
pound 4 as 1a,6b,14b-trihydroxy ent-pimara-7,15-dien-19-oic
acid.
We isolated compound 5 (½a25D 62, c 0.0011, CHCl3) as a color-
less and amorphous solid with molecular formula C20H30O6, as at-
tested by HR-ESIMS. The 1H NMR spectra of this compound and PA
were similar, except for the four typical signals of carbinolic pro-
tons at dH 4.67 (1H, dd, J = 5.0, 1.2 Hz), 4.57 (1H, d, J = 1.2 Hz),
3.92 (1H, ddd, J = 11.9, 7.9, 3.8 Hz), and 3.82 (1H, t, J = 6.3 Hz) ver-
iﬁed for compound 5, which correlated with carbons at dC 79.7,
70.3, 64.4, and 71.5 in the HMQC spectrum of this same compound.
The long-range correlations (Fig. 2) between H-20 (3H, s, dH 0.81)
and the carbon at dC 71.5, between H-17 (3H, s, dH 1.10) and the
carbon at dC 64.4, and the multiplicity of their correlated carbinolic
protons (dH 3.82 and dH 3.92) suggested the presence of hydroxyl
groups at C-1 (dC 71.5) and C-11 (dC 64.4). An NOE effect (Fig. 3) be-
tween H-11 and H-20 revealed that the OH moiety insert at C-11 is
b-oriented. The triplet at dH 3.82, attributed to H-1, indicated that
this proton is in the equatorial position, which allowed us to assign
the relative stereochemistry of H-1 as a, as previously reported for
compound 4. The experimental (t, J = 6.3 Hz; Table 1) and calcu-
lated (J = 3.8, 3.7 Hz) coupling constants of H-1 conﬁrmed this ori-
entation. The HMBC spectrum (Fig. 2) and the NOE experiments
(Fig. 3) evidenced that A. niger also promoted trans hydroxylation
at C-6 and C-7 in the chemical skeleton of PA. We ascribed the sig-
nal at dH 4.67 in the 1H NMR spectrum of compound 5 to H-6, dueto its long-range correlation with C-5 (dC 50.6), C-7 (70.3), C-8 (dC
137.8), and C-10 (40.5). We attributed the proton at dH 4.57 to H-7,
on the basis of the NOE enhancement observed for this hydrogen
and the protons H-6 (dH 4.67), H-20 (dH 0.81), and H-14 (1H, s,
dH 5.77). The low intensity of the NOE effect between H-6 and H-
7 and its stereo correlation with H-20 suggested that the hydroxyl
group at C-7 is b-oriented; the NOE enhancements of H-6 with H-5
(1H, d, dH 1.86, J = 5.0 Hz), H-7 (dH 4.57, low intensity), and H-18
(3H, s, dH 1.28) indicated that the hydroxyl group at C-6 is a-ori-
ented. The coupling constants of the oxymethine protons were
close to the values obtained by computational methods (Table 1),
reinforcing the relative stereochemistry proposed for the OH func-
tionalities introduced by A. niger in the chemical skeleton of PA.
The above ﬁndings led us to identify compound 5 as
1a,6b,7a,11a-tetrahydroxy ent-pimara-8(14),15-dien-19-oic acid.
3.2. Effect of PA derivatives on phenylephrine-induced rat aorta
contraction
We evaluated the ability of the PA derivatives (2–10) to inhibit
the rat aorta contraction induced by phenylephrine, an a1-selective
adrenergic agonist. Table 3 summarizes the % of inhibition of such
compounds.
Smooth muscle cells in blood vessel walls contain calcium
channels; activation of a1-adrenergic receptors in these channels
promotes calcium inﬂux and elicits contractile response through
two different molecular mechanisms; regulation of inositol
phospholipid hydrolysis and prompt contractions irrespective of
extracellular Ca2+ or by controlling the opening of membrane chan-
nels that allow inﬂux of extracellular Ca2+30,31.
Analysis of the results depicted in Table 3, allow us to conclude
that compounds 2, 3 and 6–10were able to modify the drug-recep-
tor binding or inﬂuence the intracellular transduction signals.
These results, in addition to the studies previously reported in
the literature30,32,33, reinforce the importance of this class of natu-
ral products in the search for novel effective compounds to inhibit
vascular smooth muscle contraction and further application in the
treatment of hypertension.
Our research group has demonstrated that minor modiﬁcation
in the chemical structure of diterpenes, mainly in ent-pimaranes
and ent-kauranes, signiﬁcantly affects their antispasmodic proper-
ties.30,33 In these studies we also have pointed out the importance
to investigate a great number of chemical correlated diterpenoids,
aiming to better understand the structure-activity relationship
associated with this biological property.
Scientiﬁc reports have demonstrated that the presence of one
hydrogen bond donor (HBD) group, such as hydroxyl, carboxylic
acid, or aldehyde functions, in the chemical skeleton of ent-kaura-
ne and ent-pimarane-type diterpenes is a very important structural
requirement related with their antispasmodic activity.30,33 How-
ever, a careful observation of the results obtained in this study
(Table 3), allow us to propose additional trends in the structure-
activity relationship presented by such compounds. Comparison
of the inhibition elicited by PA (1; 73.2%) and 9 (58.8%) with the
value displayed by 10 (10.5%), leaded us to conclude that the
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instead of an HBD group, drastically diminishes the ability of
ent-pimarane diterpenes to inhibit the phenylephrine-induced
contraction. This same relationship was previously described for
ent-kaurenoic acid, where the methylation of its C-19 carboxyl
group reduces its activity.34 Analyses of the results observed for
compounds 1, 2 and 7 (Table 3), which contains the same HBD
group at C-19, denotes that the insertion of an additional HBDmoi-
ety at C-7 (2; 16.8%) also reduces the activity. However, such effect
is not observed when the C-7 insertion is changed to a HBA group
(7; 61.5%). Finally, when considering compounds 4 and 5, it is
clearly noted that multiple hydroxylation of PA leaded to a com-
plete lack of activity.
Taking into account all the structure-activity relationship con-
siderations at positions C-7 and C-19, we conclude that the pres-
ence of a HBD at C-7 and a HBA at C-19, as seen in diterpene 8
(82.5%), resulted in an improved activity when compared to PA.
All these information highlights the importance of such positions
in chemical modiﬁcations studies to be considered as a strategy
in the search for novel ent-pimarane diterpenes with antispas-
modic properties.
In general, this report highlights the importance to study novel
ent-pimaranes and ent-kauranes in a structure-activity context, to
promote the total elucidation of the structural features involved in
the antispasmodic activity displayed by this class of natural
compounds.
4. Conclusions
Incubation of ent-pimara-8(14),15-dien-19-oic acid (PA, 1) with
A. niger, afforded three new compounds. The main microbial reac-
tions involved hydroxylation, dehydrogenation between C-6 and C-
7, and transmigration of the double bond from C-8/C-14 to C-7/C-8.
The two latter reactions are not common in microbial transforma-
tion promoted by Aspergillus species and denote that the biotrans-
formation process based on A. niger strains increases the diversity
of chemical entities. Among the evaluated compounds, only diter-
pene methyl l7a-hydroxy-ent-pimara-8(14),15-dien-19-oate (8)
showed to be more effective than PA, thus denoting that this
metabolite could potentially exert antihypertensive effects
in vivo. In a structure-activity relationship context, our results
highlight that it is important to study the antispasmodic potential
of a large number of novel ent-pimarane and ent-kaurane diter-
penes, to promote the total elucidation of the structural features
involved in the antispasmodic activity displayed by this class of
natural products.
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